Tuesday December 19, 2017
  • Beta Version
intellect logo

Home IP FLASH WIPO AND IFPMA LAUNCHES PATENT COLLABORATION

WIPO AND IFPMA LAUNCHES PATENT COLLABORATION

INTELLECT DESK
WIPO AND IFPMA LAUNCHES PATENT COLLABORATION

Francis Gurry, the Director General of World Intellectual Property Organization (WIPO) and Thomas Cueni, DG of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) have recently signed an agreement named “Pat-INFORMED” to uplift information generation system in the medical field using gateways. It will offer new tools and resources to determine the existence of patents relevant to products sought by procurement bodies’ disease-management strategies. 

While patent information is readily available, resources that directly link granted patents to marketed medicines are currently only limited to certain countries (e.g. the USA’s ‘Orange Book’) or available through private third-party databases. 

For successive information conveyance, a database is created. This database will be beneficial for the citizens, allowing them to directly connect with the medical practitioners in order to solve their problem.  Currently, twenty research-based biopharmaceutical companies have made information accessible through the database. 

“Pat-INFORMED will make it easier for procurement experts to assess the patent status of medicines, underlining how a well-designed and implemented patent system incentivizes innovation while making available and accessible key information about patented inventions,” says Gurry. 

“We can proudly say that this collaboration with WIPO shows the private sector’s initiative to propose practical solutions to reduce the complexity around patent information. Helping ease access to patent information for public health authorities can help them establish smarter procurement strategies, one building block of improved global health,” adds Cueni.

In addition to the database, participants have committed to respond in good faith to a procurement agency’s bonafide and reasonable requests for additional patent information related to a product of interest. 

The online operations are speculated to be functional from mid-2018. Indeed, it will provide patent information for small molecule products within oncology; hepatitis C, cardiovascular, HIV, diabetes, and respiratory therapy areas and any products on the WHO Essential Medicines List which are not within the therapy areas.

For the second phase, the program is expected to expand to cover all therapeutic areas and explore the inclusion of complex therapeutics.
 

October 22, 2017
Kazifarms Kitchen

Recent Posts


FUTURE SAMSUNG GALAXY PHONES COULD READ YOUR PALMS

Samsung files a patent for fetching patterns of password with palm verification.

NEW BARBIE DONS A HIJAB!

The world’s favourite beauty queen has been spotted in a hijab for the first time ever in a tribute to the bold Ibtihaj Muhammad, the first American Olympian to compete...

SEASTEADING: SET TO BECOME REALITY

Scientists, researchers and governments alike are looking to build the world’s first autonomous floating village by 2020.

HOLOGRAM TECHNOLOGY IS ALL SET FOR NEW HEIGHTS

3D experience in the comfort of your own home.

BIRCH WATER - THE NEWEST TREND IN HEALTHY HYDRATION

Plant-derived waters are an excellent source of hydration – providing the benefits of water with added electrolytes and superior taste, but without enhancing calorie intake by much. A prime example...